Frost & Sullivan

APRIL 25, 2023

years, to become a truly global company with a diverse mix of public sector and biopharma clients. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world. Christine Dingivan said, “This award recognizes the efforts of everyone who works at Emmes.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

Frost & Sullivan

JUNE 24, 2024

Antibody-Drug Conjugate (ADC) Targets: Current and Future Targets Remains a Priority Focus Big biopharma has embraced the trend of transitioning primary cancer treatment from chemotherapy to innovative targeted treatments since the ADC market is projected to grow at a CAGR of 25.4%

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Collaboration Ecosystems 52

Frost & Sullivan

APRIL 3, 2024

Simtra BioPharma Solutions announced over $250 million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana. AbbVie introduced a customized risk-based governance model for agile and compliant operations in a highly regulated and risk-sensitive environment.

Biopharmaceuticals 59

Biopharmaceuticals Biopharma Biotechnology Life science 59

LaVoie Health Science Blog

JULY 1, 2020

Given the number of public companies – including many blue-chip pharma and biopharma large caps – that have seen their stock prices swing wildly, from this strict valuation perspective alone, the current environment seems as if it should present a historic opportunity to activist investors. The current activism landscape, H1-2020.

Life science 52

Life science Biotech Biopharma Value creation 52

Frost & Sullivan

JULY 22, 2021

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Biotech 98

Biotech Biopharmaceuticals Biotechnology Government 98

Frost & Sullivan

MAY 12, 2021

Multi-dimensional Collaboration : Partnership models matching the needs of different stakeholders, including patients, physicians, suppliers, and government agencies. About Frost & Sullivan.

Biopharmaceuticals 52

Biopharmaceuticals Life science Construction Government 52

LaVoie Health Science Blog

JULY 16, 2021

In his 2018 Annual Letter to CEOs, Blackrock’s CEO Larry Fink wrote “a company’s ability to manage environmental, social, and governance matters demonstrate the leadership and good governance that is so essential to sustainable growth, which is why we are increasingly integrating these issues into our investment process.”.

Life science 69

Life science Biopharma Biotech Biotechnology 69

Jake Jorgovan

FEBRUARY 5, 2025

The Value of a Biopharma Consulting Firm Beyond mere compliance, these consultants offer strategic vision. BCG in the Biopharma Industry : BCG excels in biopharma consulting, focusing on digital tools, data, and analytics to enhance R&D and commercial strategies, and operational excellence in drug development.

Biopharmaceuticals 130

Biopharmaceuticals Biopharma Biotech Life science 130

Frost & Sullivan

MARCH 16, 2025

of Competitors 80, with revenue greater than $1.0 billion, and Thermo Fisher acquired Olink for $3.1 billion.

Biopharma 52

Biopharma Strategic alliances Strategic partnership Ecosystems 52